Search

Your search keyword '"Yamagishi K"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Yamagishi K" Remove constraint Author: "Yamagishi K" Topic business Remove constraint Topic: business
25 results on '"Yamagishi K"'

Search Results

1. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019

2. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019

3. Adiposity and risk of decline in glomerular filtration rate : Meta-analysis of individual participant data in a global consortium

4. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis

5. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

6. Relative risks of Chronic Kidney Disease for mortality and End Stage Renal Disease across races is similar

7. Edoxaban versus warfarin in patients with atrial fibrillation

8. Age and Association of Kidney Measures With Mortality and End-stage Renal Disease

9. Past Decline Versus Current eGFR and Subsequent Mortality Risk

10. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

11. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate

12. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

13. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data

14. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

15. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

16. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis

17. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48

18. General reportrecommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine

19. A framework for quantifying net benefits of alternative prognostic models

20. [Light-induced retinal damage in pigmented rabbit--2. Effect of alpha-tocopherol]

21. Global, regional, and national burden of stroke and its risk factors, 1990–2019 : a systematic analysis for the Global Burden of Disease Study 2019

22. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

23. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

24. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

25. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019

Catalog

Books, media, physical & digital resources